SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-17-000012
Filing Date
2017-03-15
Accepted
2017-03-15 17:09:47
Documents
3
Period of Report
2017-03-15
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdtx8-k2017x03x15.htm 8-K 26978
2 EARNINGS RELEASE ex9912017-03x15.htm EX-99.1 76932
3 cdtxcidara4q2016earni_image1.jpg GRAPHIC 1904
  Complete submission text file 0001610618-17-000012.txt   107888
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 17692030
SIC: 2836 Biological Products, (No Diagnostic Substances)